Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model.
The National Hospital, University of Oslo, Oslo, Norway.
A E
AE
Fiane
V
V
Videm
J D
JD
Lambris
O R
OR
Geiran
J L
JL
Svennevig
T E
TE
Mollnes
D000818:Animals; D001803:Blood Transfusion; D003167:Complement Activation / Q000502:physiology*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D016756:Immunoglobulins, Intravenous